Consultation activity of two Slovak centres for pharmacotherapy during pregnancy and lactation;Konzultačná činnost' dvoch Slovenských centier pri farmakoterapii v gravidite a laktácii

Casopis Lekaru Ceskych

Volumn 145, Issue 2, 2006, Pages 154-159

  Tisoňová, Jana ^a,c   Magulova L ^b   Goboova M ^b   Wawruch, M ^a   Lassanova, M ^a   Bozekova L ^a   Kriska M ^a   Perlík, František ^d   Hájek, Zdeněk ^e  

^a Farmakologicky Ustav   (Slovakia)

^b Fakultna Nemocnica s Poliklinikou   (Slovakia)

^c UK a VFN ^*  (Slovakia)

^d CHARLES UNIVERSITY   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Drug; Lactation; Pregnancy; Teratogenicity

Indexed keywords

ANTIDIABETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; DANAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETRETINATE; ISOTRETINOIN; METHOTREXATE; MISOPROSTOL; OPIATE; PHENYTOIN; PSYCHOTROPIC AGENT; RETINOID; TETRACYCLINE; THIAMAZOLE; WARFARIN; DRUG;

ARTICLE; CONSULTATION; DECISION MAKING; DRUG SAFETY; DRUG USE; FOOD AND DRUG ADMINISTRATION; HEALTH CENTER; HEALTH PRACTITIONER; INFORMATION CENTER; LACTATION; NONHUMAN; PREGNANCY; PREGNANT WOMAN; RETROSPECTIVE STUDY; RISK FACTOR; DRUG INFORMATION; FEMALE; HUMAN; PATIENT REFERRAL; PREGNANCY COMPLICATION; SLOVAKIA; STATISTICS;

DRUG INFORMATION SERVICES; FEMALE; HUMANS; LACTATION; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; REFERRAL AND CONSULTATION; SLOVAKIA;

EID: 33144466317     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Reid, J. L., Rubin, P. C., Whiting, B.: Clinical Pharmacology, 6. ed. Oxford Blackwell Science Ltd., 2001, s. 37-42.
2. Lukáčová, I., Kriška, M., Božeková, L.: The utilization of drugs in pregnancy in Slovak Republic. BJCP, Abstracts of CPT 2000, Florencia, 2000, s. 141.
3. Magulová, L. Göboová, M., Sirotiaková, J. et al.: Consultations on safe drugs use in pregnancy and lactation. Book of Abstracts of 33.European Symposium on Clinical Pharmacy, Praha, 2004; s. 38.
4. Ďurišová, A., Magulová, L.: Drug use problem in pregnancy. Bratisl. Lek. Listy, 2004, 105, s. 123-124.
5. Webster W. S., Freeman, J. A. D.: Prescription drugs and pregnancy. Expert. Opin. Pharmacother., 2003, 3, s. 949-961.
6. www.fda.gov
7. Janekova, E.: Stanovenie bezpečnosti farmakoterapie v gravidite. Interná Med., 2002, 2, s. 316-317.
8. FASS 2002 (The Swedish catalogue of approved medical products)
9. www7.health.gov.au/tga/docs/html/adec/adec.htm
10. Levine, G. L.: Pocket guide to commonly prescribed drugs, 3. ed. Appleton&Lange, 1999, 422 s.
11. Irl, C., Hasford, J.: Assessing the safety of drugs in pregnancy. Drug Safety, 2000, 22, s. 169-177.
12. Vallance, P.: Drugs and the fetus. BMJ, 1996, 312, s. 1053-1054.
13. Kriška, M.: Vybrané kapitoly z farmakológie. Fetálna a neonatálna farmakológia. Polygrafické stredisko UK, 1992, 49 s.
14. Suchopár, J.: Léky v těhotenství. Praha, Panax, 2000, 70 s.